17 March 2025
Swissmedic: Newly appointed Swissmedic Expert Committees start work
The Swissmedic Agency Council has appointed new members to the independent expert committees (Swissmedic Medicines Expert Committees, SMEC) as part of the regular overall renewal for the 2025-2028 term of office. SMEC assist Swissmedic with the scientific evaluation of authorisation applications, market surveillance and the granting of authorisations. These experts on human and veterinary medicinal products provide Swissmedic with additional expertise and make a valuable contribution to ensuring that patients in Switzerland have access to safe, effective and high-quality medicinal products.
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
European Medicines Agency: Highlights of the September 2026 Management Board meeting